Flu Vaccine and Medication

Guidance for Influenza Vaccination and Timing of Medication among Patients with Autoimmune and Inflammatory Rheumatic Diseases

The physicians at Arthritis and Rheumatism Associates, P.C. advise our patients ≥ 65 years and those with autoimmune and inflammatory rheumatic diseases (AIIRD) age > 18 and < 65 years on immunosuppressive medication to receive the influenza vaccination with adjuvant. All other patients should receive the regular influenza vaccination without adjuvant.  

For patients on either methotrexate and/or rituximab, we advise the following: 

Medication Timing Consideration for Medication and Influenza Vaccine
Methotrexate Withhold for 2 weeks after vaccination, if disease activity permits
Rituximab Administer vaccination on schedule. Delay medication for at  least 2 weeks after vaccination, if disease activity permits
All other immunosuppressive medicationsNo modification necessary

If patients receive both the COVID and influenza vaccinations on the same day, then follow the COVID vaccination timing guidelines.

© 2026 All Rights Reserved.